Shameek Konar - 29 Dec 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.

Role: Member of 10% owner group
Signature: /s/ Shameek Konar
Issuer symbol: CMRA on OTC
Transactions as of: 29 Dec 2023
Net transactions value: +$112,500
Form type: 4
Filing time: 02 Feb 2024, 19:48:13 UTC
Previous filing: 02 Feb 2024
Next filing: 28 May 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMRA	12.0% Senior Secured Convertible Notes	Purchase	$112,500				$112,500	29 Dec 2023	Common Stock	2,045,454	$0.0550	By Regolith Capital Investments L.P.	F1, F2
transaction	CMRA	Warrants to Purchase Common Stock	Purchase	$0	+4,090,908		$0.000000	4,090,908	29 Dec 2023	Common Stock	4,090,908	$0.0550	By Regolith Capital Investments L.P.	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Regolith Capital Investments, L.P. ("Regolith") entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which Regolith acquired (i) $112,500 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the "Notes") and (ii) 4,090,908 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share ("Common Stock"), at an exercise price of $0.055 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof.
F2	The reporting persons are general partners of Regolith and disclaim beneficial ownership of the securities held by Regolith except to the extent of their pecuniary interest therein

Content

Regolith Capital Investments, L.P. ("Regolith") entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which Regolith acquired (i) $112,500 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the "Notes") and (ii) 4,090,908 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share ("Common Stock"), at an exercise price of $0.055 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof.

The reporting persons are general partners of Regolith and disclaim beneficial ownership of the securities held by Regolith except to the extent of their pecuniary interest therein